Sepsis and Septic Shock: Surviving Sepsis Campaign Guidelines

Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection, while septic shock is a subset of sepsis with circulatory and cellular/metabolic dysfunction associated with higher mortality risk. [KEY_CONCEPT] The current definitions, established by the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3), have replaced the previous SIRS-based criteria.

Sepsis-3 Definitions:

• Sepsis: Life-threatening organ dysfunction due to dysregulated host response to infection (qSOFA ≥2 or SOFA increase ≥2)
• Septic Shock: Sepsis with persisting hypotension requiring vasopressors to maintain MAP ≥65 mmHg AND lactate >2 mmol/L despite adequate volume resuscitation

[HIGH_YIELD] Epidemiological Impact:

• Affects >30 million people worldwide annually
• Mortality rates: Sepsis 15-30%, Septic Shock 40-60%
• Leading cause of death in hospitalized patients
• Healthcare costs exceed $24 billion annually in the US

Pathophysiology Overview: Sepsis involves a complex interplay of pro-inflammatory and anti-inflammatory responses leading to:

• Endothelial dysfunction with increased vascular permeability
• Coagulation activation with microvascular thrombosis
• Metabolic dysfunction with cellular hypoxia
• Immune dysregulation with both hyperinflammation and immunosuppression

[CLINICAL_PEARL] The transition from compensated to decompensated shock occurs when cellular oxygen delivery becomes inadequate despite normal or elevated cardiac output, making early recognition critical.

Early Recognition is Critical - sepsis presents with variable clinical manifestations depending on the source of infection, host factors, and stage of illness progression.

Quick Sequential Organ Failure Assessment (qSOFA):

[HIGH_YIELD] qSOFA ≥2 points identifies patients with suspected infection at higher risk for poor outcomes and should prompt consideration of sepsis.

Common Clinical Presentations by Source:

Respiratory (40%):

• Pneumonia with dyspnea, cough, fever
• May present with confusion in elderly

Genitourinary (25%):

• UTI/pyelonephritis with dysuria, flank pain
• May have minimal urinary symptoms in elderly

Abdominal (15%):

• Peritonitis, cholangitis, diverticulitis
• Abdominal pain, nausea, vomiting

Bloodstream (10-15%):

• Central line-associated infections
• Endocarditis in high-risk patients

[CLINICAL_PEARL] Red Flag Signs:

• Altered mental status (often earliest sign in elderly)
• Hypotension unresponsive to fluid challenge
• Oliguria <0.5 mL/kg/hr
• Mottled skin or prolonged capillary refill
• Lactate elevation >2 mmol/L

High-Risk Populations:

• Age >65 years
• Immunocompromised patients
• Chronic kidney/liver disease
• Diabetes mellitus
• Malignancy
• Recent hospitalization or invasive procedures

Surviving Sepsis Campaign Hour-1 Bundle emphasizes rapid diagnostic evaluation and intervention within the first hour of recognition.

Essential Diagnostic Workup:

SEPSIS DIAGNOSTIC ALGORITHM

1. Clinical Suspicion (qSOFA ≥2 + infection) ↓
2. Immediate Laboratory Studies: • Complete blood count with differential • Comprehensive metabolic panel • Arterial blood gas • Lactate level • Procalcitonin (if available) • Liver function tests • Coagulation studies (PT/PTT/INR) ↓
3. Microbiological Studies (before antibiotics if possible): • Blood cultures (2 sets from different sites) • Urine culture • Source-specific cultures • Consider respiratory cultures if pneumonia ↓
4. Imaging Studies: • Chest X-ray (all patients) • CT abdomen/pelvis if abdominal source • Echocardiogram if endocarditis suspected ↓
5. Calculate SOFA Score for Severity Assessment

[HIGH_YIELD] SOFA Score Components:

Biomarker Interpretation:

• Lactate >2 mmol/L: Tissue hypoperfusion marker
• Procalcitonin >0.5 ng/mL: Suggests bacterial infection
• WBC: May be elevated, normal, or decreased

[KEY_CONCEPT] Sepsis Diagnosis Requires:

1. Suspected or documented infection PLUS
2. Acute increase in SOFA score ≥2 points

[CLINICAL_PEARL] Blood cultures should be obtained before antibiotics when possible, but antibiotic administration should never be delayed >45 minutes for culture collection.

Surviving Sepsis Campaign Hour-1 Bundle (2018 Update):

Immediate Management Protocol:

HOUR-1 SEPSIS BUNDLE

1. MEASURE lactate level • Remeasure if initial >2 mmol/L

2. OBTAIN blood cultures before antibiotics • Don't delay antibiotics >45 minutes

3. ADMINISTER broad-spectrum antibiotics • Within 1 hour of recognition

4. BEGIN rapid administration of crystalloid • 30 mL/kg if hypotensive or lactate ≥4 mmol/L

5. APPLY vasopressors if hypotensive • During or after fluid resuscitation • Target MAP ≥65 mmHg

[HIGH_YIELD] Antibiotic Selection Strategy:

Empirical Therapy by Source:

• Community-acquired pneumonia: Ceftriaxone + azithromycin or fluoroquinolone
• Healthcare-associated: Piperacillin-tazobactam or cefepime ± vancomycin
• Abdominal: Piperacillin-tazobactam or ceftriaxone + metronidazole
• Genitourinary: Ceftriaxone or fluoroquinolone
• Unknown source: Vancomycin + piperacillin-tazobactam

Fluid Resuscitation Protocol:

• Initial: 30 mL/kg crystalloid within 3 hours
• Preferred: Balanced crystalloids (lactated Ringer's, Plasma-Lyte)
• Avoid: Hydroxyethyl starch solutions
• Monitor: CVP, ScvO2, lactate clearance

Vasopressor Management:

[CLINICAL_PEARL] Norepinephrine is the first-line vasopressor due to superior outcomes compared to dopamine, with less arrhythmogenicity.

Additional Management Considerations:

• Corticosteroids: Hydrocortisone 200 mg/day if refractory shock
• Source control: Urgent drainage/debridement when indicated
• Glucose control: Target 144-180 mg/dL
• DVT prophylaxis: Unless contraindicated
• Stress ulcer prophylaxis: PPI or H2 blocker

De-escalation Strategy:

• Culture-directed therapy within 48-72 hours
• Procalcitonin-guided duration (if available)
• Typical duration: 7-10 days unless complications

Acute Complications of Sepsis:

Cardiovascular:

• Distributive shock with vasodilation
• Myocardial depression (septic cardiomyopathy)
• Arrhythmias secondary to metabolic derangements

Respiratory:

• ARDS (30-50% of septic patients)
• Respiratory failure requiring mechanical ventilation
• Ventilator-associated pneumonia

Renal:

• Acute kidney injury (40-50% incidence)
• Oliguria and fluid retention
• Electrolyte imbalances

Hematological:

• Disseminated intravascular coagulation (DIC)
• Thrombocytopenia
• Coagulopathy with bleeding risk

Neurological:

• Sepsis-associated encephalopathy
• Critical illness polyneuropathy
• Delirium in 60-80% of patients

[HIGH_YIELD] Monitoring Parameters:

Organ Support Strategies:

Mechanical Ventilation:

• Low tidal volume: 6 mL/kg predicted body weight
• PEEP optimization: Individualized approach
• Prone positioning: If P/F ratio <150

Renal Replacement Therapy:

• Indication: Severe AKI with volume overload, acidosis, or uremia
• Timing: No benefit to early initiation
• Modality: CVVH vs intermittent HD based on hemodynamic stability

[KEY_CONCEPT] Recovery Monitoring:

• Lactate normalization within 24-48 hours
• Vasopressor weaning as perfusion improves
• Organ function recovery assessed by SOFA score improvement
• Infection clearance guided by cultures and biomarkers

[CLINICAL_PEARL] Post-Sepsis Syndrome affects 50% of survivors with:

• Physical impairment (weakness, fatigue)
• Cognitive dysfunction
• Psychological sequelae (PTSD, depression)
• Increased risk of recurrent infections

Long-term Monitoring:

• Follow-up at 3, 6, 12 months
• Functional assessment and rehabilitation needs
• Vaccination status update (pneumococcal, influenza)
• Chronic disease management optimization

Prognostic Factors and Outcomes:

Mortality Predictors:

• Age >65 years (OR 2.1)
• SOFA score >15 (mortality >90%)
• Lactate >4 mmol/L at 24 hours
• Number of organ failures (1 organ: 10%, ≥4 organs: 60% mortality)
• Source control achievability
• Time to appropriate antibiotics (each hour delay increases mortality 7-10%)

[HIGH_YIELD] Sepsis Mortality by Category:

• Sepsis without shock: 10-15%
• Septic shock: 40-60%
• Sepsis with ARDS: 45-55%
• Multi-organ failure: 70-80%

Quality Performance Measures:

Surviving Sepsis Campaign Bundles Compliance:

• Hour-1 Bundle completion associated with 18% relative risk reduction in mortality
• Bundle compliance varies widely (30-80% across institutions)
• Lactate measurement within 3 hours: >90% compliance target
• Antibiotic administration within 1 hour: >80% compliance target

Hospital Quality Indicators:

Prognostic Scoring Systems:

SOFA Score Interpretation:

• 0-6: <10% mortality
• 7-9: 15-20% mortality
• 10-12: 40-50% mortality
• 13-14: 50-60% mortality
• 15+: >80% mortality

[KEY_CONCEPT] Factors Improving Prognosis:

• Early recognition and bundle implementation
• Appropriate source control within 6-12 hours
• Adequate initial fluid resuscitation
• Timely vasopressor initiation
• Protocol-driven care in dedicated units

Long-term Outcomes:

• 1-year survival: 60-70% for severe sepsis survivors
• Functional independence: 40-60% at 1 year
• Cognitive impairment: 25-40% at 1 year
• Healthcare utilization: 2-3x higher in first year

[CLINICAL_PEARL] Discharge Planning:

• Medication reconciliation and antibiotic stewardship
• Rehabilitation services referral for functional impairment
• Primary care follow-up within 1-2 weeks
• Vaccination updates and infection prevention counseling
• Family education on post-sepsis syndrome recognition

Prevention Strategies:

• Infection control measures
• Vaccination programs (influenza, pneumococcal)
• Early recognition training for healthcare providers
• Rapid response teams for deteriorating patients